Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has provided an update.
Integral Diagnostics Ltd., the ASX-listed diagnostic imaging provider trading under ticker IDX, has confirmed updated details for its latest dividend relating to the six-month period ended 31 December 2025. The payment is tied to ordinary fully paid shares, with a record date of 5 March 2026, an ex-dividend date of 4 March 2026 and payment scheduled for ordinary shareholders on the stated payment date.
The company has amended its prior 24 February 2026 dividend notification to disclose the foreign exchange rate used to convert the Australian dollar-denominated dividend into New Zealand dollars and to update the share price applied under its Dividend Reinvestment Plan. The update clarifies the mechanics of the cross-border payout and DRP pricing for investors, improving transparency for shareholders in both Australia and New Zealand ahead of the dividend payment.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics Ltd. is an Australian-listed provider of diagnostic imaging services, operating through its ordinary fully paid shares under the ASX code IDX. The company focuses on medical imaging solutions across its network, serving healthcare providers and patients in Australia and New Zealand through periodic dividend distributions to shareholders.
Average Trading Volume: 862,223
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$905.7M
For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.